Cargando…
Management of ulcerative colitis
Ulcerative colitis (UC) in children is increasing. The range of treatments available has also increased too but around 1 in 4 children still require surgery to control their disease. An up-to-date understanding of treatments is essential for all clinicians involved in the care of UC patients to ensu...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4853583/ https://www.ncbi.nlm.nih.gov/pubmed/26553909 http://dx.doi.org/10.1136/archdischild-2014-307218 |
_version_ | 1782430096056909824 |
---|---|
author | Fell, John M Muhammed, Rafeeq Spray, Chris Crook, Kay Russell, Richard K |
author_facet | Fell, John M Muhammed, Rafeeq Spray, Chris Crook, Kay Russell, Richard K |
author_sort | Fell, John M |
collection | PubMed |
description | Ulcerative colitis (UC) in children is increasing. The range of treatments available has also increased too but around 1 in 4 children still require surgery to control their disease. An up-to-date understanding of treatments is essential for all clinicians involved in the care of UC patients to ensure appropriate and timely treatment while minimising the risk of complications and side effects. |
format | Online Article Text |
id | pubmed-4853583 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-48535832016-05-06 Management of ulcerative colitis Fell, John M Muhammed, Rafeeq Spray, Chris Crook, Kay Russell, Richard K Arch Dis Child Review Ulcerative colitis (UC) in children is increasing. The range of treatments available has also increased too but around 1 in 4 children still require surgery to control their disease. An up-to-date understanding of treatments is essential for all clinicians involved in the care of UC patients to ensure appropriate and timely treatment while minimising the risk of complications and side effects. BMJ Publishing Group 2016-05 2015-11-09 /pmc/articles/PMC4853583/ /pubmed/26553909 http://dx.doi.org/10.1136/archdischild-2014-307218 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Review Fell, John M Muhammed, Rafeeq Spray, Chris Crook, Kay Russell, Richard K Management of ulcerative colitis |
title | Management of ulcerative colitis |
title_full | Management of ulcerative colitis |
title_fullStr | Management of ulcerative colitis |
title_full_unstemmed | Management of ulcerative colitis |
title_short | Management of ulcerative colitis |
title_sort | management of ulcerative colitis |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4853583/ https://www.ncbi.nlm.nih.gov/pubmed/26553909 http://dx.doi.org/10.1136/archdischild-2014-307218 |
work_keys_str_mv | AT felljohnm managementofulcerativecolitis AT muhammedrafeeq managementofulcerativecolitis AT spraychris managementofulcerativecolitis AT crookkay managementofulcerativecolitis AT russellrichardk managementofulcerativecolitis AT managementofulcerativecolitis |